United States

People: Cempra Inc (CEMP.O)

CEMP.O on Nasdaq

26 May 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Moore, David 

Mr. David S. Moore is no longer President, Chief Commercial Officer of the Company effective May 5, 2017. He was Executive Vice President of the Company. From July 2013 to December 2013, Mr. Moore was Chief Business Officer of Ocera Therapeutics where he was responsible for developing the commercial plans for an orphan-designated advanced liver disease product for both the community and acute care markets. Mr. Moore was Chief Business Officer of Tranzyme Pharma from December 2012 to July 2013, and Vice President, Commercial Operations from August 2011 to January 2013, during which time he was responsible for building the commercial organization as well as in- and out-licensing clinical-stage assets. Between January 1998 and July 2011, Mr. Moore held increasing levels of responsibility in the Ortho-McNeil and Janssen divisions of Johnson & Johnson. Mr. Moore received his B.Sc. in Biology from Towson University and an M.B.A. from Lehigh University, and a second graduate degree in Health Policy Excellence from Thomas Jefferson University.

Basic Compensation

Total Annual Compensation, USD 481,833
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 903,400
Fiscal Year Total, USD 1,385,230

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --